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Context:Hypoadiponectinemia is caused by interactions between genetic and environmental fac-
tors, including the quality of dietary fats.
Objective:We investigated the association of single-nucleotide polymorphisms (SNPs) in the adi-
ponectin gene (ADIPOQ) with dietary fat intake or fatty acid (FA) composition in serum phospho-
lipids, plasma adiponectin, and insulin resistance.
Methods: Nondiabetic subjects (n 1194) were genotyped for three ADIPOQ SNPs (11377CG;
45TG; 276GT) after screening of eight sites. Dietary fat intake, FA composition in serum phos-
pholipids, adiponectin, and homeostasis model assessment of insulin resistance (HOMA-IR) were
also measured.
Results:The276Gcarriers (n1082) showed lowerhigh-density lipoprotein cholesterol (P0.024)
and adiponectin (P 0.001) but higher glucose (P 0.015) and HOMA-IR (P 0.005) than 276T/T
subjects (n 112). No associationswere found in other SNPs. After adjusted for age, sex, bodymass
index, and the proportion of 18:26 and 18:33 (biomarkers of long term essential FA intake), the
276G carriers showed lower proportions of total 3FA (P 0.026), 20:53 (P 0.021), and 22:53
(P 0.024) in serum phospholipids. Among FAs in serum phospholipids, 18:26 highly correlated
with 3-polyunsaturated FA (PUFA) intake (r  0.260, P  0.001) and adiponectin (r  0.150, P 
0.001). The276Gcarrierswith ahigherproportionof 18:26 (12.5%)exhibitedmorepronounced
characteristics, i.e. lower adiponectin (P 0.001), lower high-density lipoprotein cholesterol (P
0.004), higher HOMA-IR (P  0.013), and lower long-chain 3PUFAs (20:53, 22:53, and 22:63,
P  0.001). Additionally, the effect of 276GT on the relationship between adiponectin and
HOMA-IR was modified by 18:26 proportion.
Conclusion: ADIPOQ 276G is associated with reduced proportion of long-chain 3PUFAs in serum
phospholipids in nondiabetic Koreans. (J Clin Endocrinol Metab 95: E347–E351, 2010)
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Low circulating adiponectin, the protein produced byadipocyteC1q, and collagendomain-containing gene
(ADIPOQ), are associated with type 2 diabetes mellitus
(T2DM) and cardiovascular disease (CVD) (1, 2).
Among the single-nucleotide polymorphisms (SNPs) in
the ADIPOQ gene, 276GT is associated with reduced
circulating adiponectin, greater insulin resistance (IR),
and the increased risk of T2DM (3) or the early onset of
coronary artery disease (CAD) (4).Menzaghi et al. (5) also
showed that 276GT, either independently or as a hap-
lotype with 45TG, is associated with several features of
IR in nondiabetic Italians. In French subjects, a GG hap-
lotype from SNPs 11391GA/11377CG is signifi-
cantly associated with hypoadiponectinemia, despite no
association with IR and T2DM (6). The reasons for these
partially discrepant results are unknown but may result
from the different genetic background and potential gene-
diet interactions in the different ethnicities.
Hypoadiponectinemia is caused by interactions be-
tween genetic and environmental factors, including the
quality of dietary fats. Previous studies have reported sig-
nificant association between circulating adiponectin and
plasma fatty acids (FAs) (7, 8). In rodents, a diet rich in
3-polyunsaturated FAs (PUFAs) increases adiponectin
concentration and up-regulates adipocytes (7, 8), whereas
saturated fat down-regulates ADIPOQ expression (9).
However, there are no studies on the association between
ADIPOQ polymorphisms and serum FA composition,
even though FA composition was a reasonably accurate
biochemical marker of long-term proportionate FA in-
take, especially for PUFAs and essential FAs (10).
Therefore, we examined whether ADIPOQ genetic
variation and dietary fat intake or FA composition of se-
rumphospholipidsmaymodulateplasmaadiponectin and
contribute to CVD risk, including the IR index.
Subjects and Methods
Study subjects
Study participantswere recruited during routine check-ups at
a health promotion center at Yonsei University Hospital (580
men, 614 women). Exclusion criteria were clinical or electro-
cardiographic evidence of CAD, stroke, myocardial infarction,
or peripheral arterial occlusive disease; diabetesmellitus (or fast-
ing glucose 126 mg/dl); abnormal liver or renal function; thy-
roid or pituitary disease; acute or chronic inflammatory disease;
and regular use of anymedications. The purpose of the studywas
carefully explained to all participants, and their informed con-
sent was obtained. The study protocol was approved by the In-
stitutional Review Board of Yonsei University.
Anthropometric parameters and blood collection
Bodymass index (BMI; kilograms per squaremeter) was calcu-
latedwithbodyweightandheight.Waist tohipratiowascalculated
withwaist andhip circumferences.Bloodpressurewasmeasured in
the left arm of the patient after a 20-min rest (TM-2654; A&D,
Tokyo, Japan). Fasting venous blood specimens (12 h) were col-
lected in EDTA-treated and plain tubes, centrifuged to give plasma
or serum, and stored at70 C until analysis.
Genotyping
Genomic DNAwas extracted using a commercially available
DNA isolation kit (WIZARD Genomic DNA purification kit;
Promega, Madison, WI). Previously reported eight ADIPOQ
SNPs (11391GA; 11377CG; H241P; Y111H;G90S;
R221S; 45TG; 276GT) were prescreened to see the minor
allele frequency of each SNP (11). Each genotyping reaction was
performed with SNP-IT assays (SNPstream 25K system; Orchid
Biosystems, Princeton, NJ).
Glucose, insulin, homeostasis model assessment
for IR (HOMA-IR), and lipid profile
Fasting glucose was measured by a glucose oxidase method
(Beckman glucose analyzer; Beckman Instruments, Irvine, CA).
Insulin was measured by RIAs with commercial kits (Immuno
Nucleo Corp., Stillwater, MN). IR was calculated with the ho-
meostasis model assessment. Fasting total cholesterol and triglyc-
erides were measured using commercially available kits (Hitachi
7150 autoanalyzer; Hitachi Ltd., Tokyo, Japan). High-density li-
poprotein (HDL) cholesterol in the supernatant was measured by
an enzymatic method and low-density lipoprotein cholesterol was
indirectlyestimated insubjectswithserumtriglyceride less than400
mg/ml using the Friedewald formula.
Plasma adiponectin and FA composition in serum
phospholipids
Plasma adiponectin was measured using an enzyme immuno-
assay (human adiponectin ELISA kit; B-Bridge International Inc.,
San Jose, CA) and a Victor2 (PerkinElmer Life Sciences, Turku,
Finland). Serum phospholipid FA compositionwas analyzed using
the modified method of Folch et al. (12) and Lepage and Roy (13)
with gas chromatography (Hewlett Packard 5890A; Palo Alto,
CA).
Dietary intervention program and assessment of
dietary intake/physical activity level
Subjects’ diets were assessed using a 24-h recall method (3 d
dietary records).Dietary energyvalues andnutrient contentwere
calculated using CAN-pro 2.0 (KoreanNutrition Society, Seoul,
Korea). Total energy expenditures (kilocalories per day) were
also calculated.
Statistical analysis
Statistical analyses were performed with SPSS version 12.0
(SPSSInc.,Chicago,IL).ExecutiveSNPanalyzer(http://www.istech.
info/silicosnp/index.html?)wasused for theHardy-Weinberg equi-
librium test and linkage disequilibrium test. One-way ANOVA
with the Bonferroni correctionwas used to test the genotype effect.
General linear models approach was also used for the comparison
with adjustment for confounding factors. Pearson and partial cor-
relation coefficients were used to determine the relationship be-
tween variables. Each variable was examined for normal distribu-
tion, and skewed variables were log transformed. For descriptive
purposes, mean values are presented using untransformed values.
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Results are expressed asmean SD. A two-tailed value ofP 0.05
was considered statistically significant.
Results
Distribution of 11377C>G, 45T>G, and 276G>T
genotype in the entire population
AmongeightSNPs inADIPOQ, theminorallele frequen-
cies of 11391GA, H241P, Y111H, G90S, and R221S
were less than 2%; therefore, only SNPs 11377CG,
45TG,and276GTwere further analyzed.Genotypedis-
tributions did not deviate from the Hardy-Weinberg equi-
librium, and the minor allele frequency of each SNP was
consistentwithprevious reports inKoreanpopulations (11).
Among the three SNPs, 45TG and 276GT were found
highly linked (D 1; R2 0.195, P 0.001). However,
haplotype analysis did not provide infor-
mation beyond that revealed by each
SNP; therefore, we presented the results
of individual ADIPOQ polymorphisms.
Clinical characteristics and dietary
intakes according to ADIPOQ SNP
genotypes
Nosignificantgenotype-associateddi-
fferenceswere observed in age, sex distri-
bution, BMI, waist to hip ratio, cigarette
smoking, alcohol consumption, blood
pressure, lipid profile except HDL cho-
lesterol, and total energy intake and en-
ergy intake percent derived from macro-
nutrients (data not shown). Compared
with 276T/T subjects, 276G carriers
showed lower concentrations of HDL
cholesterol (P 0.024) and adiponectin
(P0.001), higher levels of glucose (P
0.015), insulin (P  0.006), and
HOMA-IR (P0.005) and lower intake
of PUFAs with lower PUFA/saturated
fatty acid (SFA). None of the other SNPs
were significantly associated with these
variables (data not shown).
Effect of ADIPOQ 276G>T on
plasma adiponectin, long-chain
3PUFAs in serum phospholipids,
and insulin resistance according to
the proportion of linoleic acid
SNP276GTwas significantly asso-
ciated with FA proportion in serum
phospholipids. After adjusting for age,
sex, BMI, and the proportion of 18:26
and 18:33 (biomarkers of long term
essential FA intake), 276GTwas still associatedwith the
proportion of total 3 (P  0.026), 20:53 (P  0.021),
and 22:53 (P 0.024), adiponectin (P 0.001), glucose
(P 0.002) and insulin (P 0.035), and HOMA-IR (P
0.030). Further adjustment for the proportion of total
3PUFA in serum phospholipids still maintained the signif-
icant association of 276GT with HDL cholesterol (P 
0.029), adiponectin (P  0.001), and glucose (P  0.002).
On the other hand, the significant effect on insulin and
HOMA-IRturnedtoatendencyafter thefurtheradjustment.
Among the FAs in serum phospholipids, 18:26 highly
correlated with PUFA intake (r  0.260, P  0.001) and
plasma adiponectin (r 0.150, P 0.001). Therefore, sub-
jects were divided into two subgroups according to the me-
dian value of 18:26 (12.5% vs.  12.5%). In subjects
FIG. 1. Effect of ADIPOQ 276 GT on plasma adiponectin and the proportions of long-chain
3PUFAs in serum phospholipids according to the proportion of 18:26 in serum phospholipids
(below or above the median level, 12.5%). Data are mean SD.§, Tested by logarithmic
transformation. Tested by one-way ANOVA followed by Bonferroni method (P0, unadjusted) and
generalized linear model with adjustment for age, sex, BMI, and proportions of 18:26
and 18:33 in serum phospholipids (P1, adjusted). Sharing the same alphabet indicates
no significant difference (P1  0.05) in mean values. EPA, Eicosapentaenoic acid; DPA,
docosapentaenoic acid; DHA, docosahexaenoic acid.
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with a higher proportion of 18:26, 276G carriers showed
lower levelsof adiponectin (P0.001), 20:53 (P0.005),
22:53 (P 0.003), and 22:63 (P 0.012) than 276T/T
subjects after the adjustment (Fig. 1). The 276Gcarriers also
showed higher levels of glucose (G/G: 92.1  9.49, G/T:
90.2  9.38, T/T: 85.4  11.1 mg/dl; P  0.001) and
HOMA-IR (G/G: 2.03  1.10, G/T: 2.10  1.08, T/T:
1.720.85;P0.013) and lower levels ofHDLcholesterol
(P  0.004) and adiponectin (P  0.001). Further adjust-
ment for the proportion of long-chain 3PUFA in serum
phospholipids still maintained the significant association
(glucose, P  0.001; HOMA-IR, P  0.002; HDL choles-
terol, P  0.001; adiponectin, P  0.001). In contrast, in
lower 18:26, 276GT was not associated with adiponec-
tin, glucose, HOMA-IR, or FA composition in serum
phospholipids.
Figure 2 shows the relationship between adiponectin
levels andHOMA-IRaccording to 276GTand the levels
of 18:26 proportion. The 276G carriers had the negative
relationship between the two variables, regardless of 18:
26 proportion. On the other hand, TT subjects showed
the significant negative correlation in higher proportionof
18:26 after the adjustment
Discussion
This study shows a significant association of ADIPOQ
276GT with plasma adiponectin and long-chain 3PU-
FAs in serum phospholipids after adjustment for the pro-
portions of 18:26 and 18:33, biomarkers of long-term
essential FA intake (14). Interestingly, the association of
276GTwith plasma adiponectin, long-chain 3PUFAs,
and IR was more pronounced in subjects with higher pro-
portion of 18:26 in serum phospholipids.
Circulatingadiponectins ismodulated
by ingestion of certain FAs or by changes
in serum FA composition (7, 8). Lower
proportions of serum phospholipid total
3FAs in our 276 G carrier might reflect
a dietary intake with lower PUFA and
lower PUFA/pSFA because macronutri-
ent energy intake percent was not differ-
entaccordingto276GT.Moreover, the
higher 20:53 and 22:53 in 276T/T
subjects after adjustment for proportions
of 18:26 and 18:33 could indicate a
close link between 3FAs and adi-
ponectin. Ferna´ndez-Real et al. (15)
also showed that 3FA proportion in
plasma FA profiles is highest in individ-
uals with increased circulating adiponec-
tin, and thisassociationpersists after con-
trolling for age, BMI, and remaining individual FAs.
In this study, the association between ADIPOQ SNPs,
adiponectin, and IRwas found only for SNP276, consistent
withprevious findings that the 276Gallele is associatedwith
lower circulating adiponectin and is an independent contrib-
utor for the increasedCVDrisk inKoreans (11) and the early
onset of CAD (4). The major biological functions of adi-
ponectin dependon the activationofAMP-activatedprotein
kinase primarily in skeletal muscles, which increases FA ox-
idation and glucose uptake, thereby improving insulin sen-
sitivity (16). The mechanism whereby serum phospholipid
3PUFAs might impact peripheral adiponectin concentra-
tion, or vice versa, was not elucidated in this study. One
potential pathway involves activation of peroxisomal pro-
liferator-activated receptor (PPAR)-, a transcriptional reg-
ulator that interactsdirectlywith theADIPOQpromoter. In
fact, eicosapentaenoic acid and docosahexaenoic acid may
up-regulate ADIPOQ by acting as ligands of PPAR- (17),
and pharmacological activationwith PPAR- agonists leads
to increased adiponectin (18).
Circulatingadiponectin levels areknowntobehighlyher-
itable (50%). Additionally, dietary FAs and gene-diet in-
teractions were found to modulate plasma adiponectin and
contribute to IR, a risk factor forT2DMandCVD(19).Our
results indicateassociationsbetweendietaryPUFAsorserum
phospholipidPUFAs,276GT,circulatingadiponectin,and
HOMA-IR, despite a much lower percentage of fat energy
intake in the study subjects and in the general Korean pop-
ulation than in white populations (20). Recently Koreans
havethe increasedfatenergypercent intheirdietsandrapidly
increasedmortality rateof ischemicheartdisease (20). Itmay
suggest that theKoreanpopulationisgeneticallypredisposed
to be negatively affected by adverse dietary changes at a
lower threshold than whites.
FIG. 2. Relationship between adiponectin and IR according to ADIPOQ 276GT polymorphism
and the proportion of 18:26 in serum phospholipids (below or above the median level, 12.5%).
§, Tested by logarithmic transformation and tested by Pearson correlation (r0) or partial correlation
analysis (r1). r0, Correlation coefficient, unadjusted; r1, correlation coefficient after adjusted for
age, sex, BMI, and proportions of 18:26 and 18:33 in serum phospholipids.
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Our results suggest that when low intake of PUFA or
PUFA/SFA are superimposed on a high-risk 276G carrier
background,the lowerproportionofPUFAs,especially long-
chain3PUFAs inserumphospholipids, couldresult inmore
pronounced hypoadiponectinemia and IR than for other ge-
notypes, thus accounting for the increasedCVD risk. There-
fore, substitution of soy, vegetable, or fish oil for saturated
fat, even in a low-fat diet,might be beneficial for 276Gallele
carriers (19).
Our results have the limitations of all cross-sectional and
observationalstudies; thus,cause-effectrelationshipsandthe
mechanistic interactionsbetweenADIPOQgeneticvariabil-
ity, adiponectin concentration, dietary fat, and other bio-
chemical factors cannot be easily established. Despite these
limitations, it confirmed the relationship betweenADIPOQ
276GT and circulating adiponectin and IR shown inmul-
tiple independentpopulations (3–5,11,19)and identifiedan
interesting association of the 276G allele with reduced pro-
portionof long-chain3PUFAsinserumphospholipidsafter
adjustment for long-term essential fatty acid intake.
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